ストックスクリーナーアプリを入手
3.60
2.96%
-0.11
Vaccinex Inc (VCNX) 最新ニュース
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Vaccinex Reports Promising Alzheimer's Drug Data, Raises $8.35M Amid Financial Challenges | VCNX Stock News - StockTitan
Vaccinex Inc (VCNX) Quarterly 10-Q Report - Quartz
Vaccinex secures $2.15 million in private placement By Investing.com - Investing.com UK
ARMISTICE CAPITAL, LLC Acquires Shares in Vaccinex Inc - GuruFocus.com
Latest Company News - Investing.com
Vaccinex inks multiple antibody discovery deals using ActivMAb By Investing.com - Investing.com Canada
Vaccinex inks multiple antibody discovery deals using ActivMAb - Investing.com India
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC - GlobeNewswire
Vaccinex Lands Major Pharma Deals: Amgen, Merck Partner on Breakthrough Antibody Tech | VCNX Stock News - StockTitan
Vaccinex Reports Improved Immunity Correlating with - GlobeNewswire
VCNXVaccinex, Inc. Latest Stock News & Market Updates - StockTitan
Vaccinex's Pepinemab Breakthrough: New Data Shows Enhanced Cancer Immunotherapy Success | VCNX Stock News - StockTitan
Vaccinex reports progress in Alzheimer's treatment study By Investing.com - Investing.com Canada
Vaccinex reports progress in Alzheimer's treatment study - Investing.com India
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 - GlobeNewswire
Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain - Nasdaq
Vaccinex stock tanks 40% despite positive Alzheimer’s study update - MSN
Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Barchart
Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024 - GlobeNewswire
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Orange Juice (OJX25) Quote - The Globe and Mail
Antibody Library Technology Market Report to 2032 -AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen – IndiaPolitics.com - IndiaPolitics.com
Vaccinex faces potential Nasdaq delisting over equity shortfall - Investing.com India
BTIG Research’s latest rating for VCNX stock - Knox Daily
Vaccinex faces potential Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada
Company’s Banking Shares: Up -90.42% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
Post-Trade Analysis: Vaccinex Inc (VCNX) Slides -27.92, Closing at 1.73 - The Dwinnex
Vaccinex stock hits 52-week low at $2.98 amid market challenges - Investing.com
Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com Canada
VSME’s price-to-free cash flow ratio: What it means for investors - US Post News
Short Interest in Victory Square Technologies Inc. (OTCMKTS:VSQTF) Declines By 79.4% - Defense World
Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by Victory Capital Management Inc. - Defense World
WUXI BIO Buys back ~3.32M Shrs for ~$42.55M Ytd - AASTOCKS.com
Vaxcyte Inc (PCVX) receives a Buy rating from Mizuho - Knox Daily
Victrex plc (LON:VCT) Insider Jane Toogood Acquires 508 Shares - MarketBeat
Victrex Director Buys Shares, Signals Confidence - TipRanks
Bank of New York Mellon Corp Boosts Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) - Defense World
StockNews.com Initiates Coverage on Vector Group (NYSE:VGR) - Defense World
VICR Investors Have Opportunity to Lead Vicor Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
The Gross Law Firm Reminds Vicor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024VICR - PR Newswire
Victory Capital Management Inc. Has $496,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World
Rhumbline Advisers Has $1.01 Million Position in V2X, Inc. (NYSE:VVX) - Defense World
Choreo LLC Takes Position in Vector Group Ltd. (NYSE:VGR) - Defense World
VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire
VICR FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
First Eagle Investment Management LLC Purchases 2,067 Shares of V2X, Inc. (NYSE:VVX) - Defense World
Vaccinex issues new warrants, secures $6.2 million in funding - Investing.com
Victory Capital Management Inc. Cuts Stake in Wyndham Hotels & Resorts, Inc. (NYSE:WH) - Defense World
Vaccinex secures $6.2 million through warrant exercises By Investing.com - Investing.com Canada
What's Going On With Vaccinex Stock Wednesday? - Benzinga
Vaccinex secures $6.2 million through warrant exercises - Investing.com India
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):